Perceptive Advisors’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-44,128
Closed -$1.04M 110
2018
Q4
$1.04M Sell
44,128
-216,548
-83% -$5.56M 0.04% 81
2018
Q3
$7.52M Sell
260,676
-207,000
-44% -$3.87M 0.2% 63
2018
Q2
$5.72M Sell
467,676
-573,000
-55% -$6.57M 0.15% 71
2018
Q1
$8.29M Hold
1,040,676
0.23% 66
2017
Q4
$7.64M Buy
+1,040,676
New +$6.49M 0.25% 60

Other funds holding CDNA

Perceptive Advisors's CDNA Position: Q1 2019 in Review

Perceptive Advisors sold out of CareDx (CDNA) in Q1 2019, closing a stake of 44,128 shares — an estimated $1.04M sold.

Perceptive Advisors first reported a position in CDNA in Q4 2017 and held it in 5 quarters. The position peaked at $8.29M in Q1 2018. 182 funds tracked by Wall St. Rank hold CDNA as of Q1 2019.

  • Perceptive Advisors reported no remaining CareDx position as of Q1 2019 after selling out during the quarter.
  • Perceptive Advisors sold 44,128 CareDx shares in Q1 2019, an estimated $1.04M.
  • Perceptive Advisors first reported a position in CareDx in Q4 2017 and held it in 5 quarters.
  • Perceptive Advisors's CareDx position peaked at $8.29M in Q1 2018.
  • 182 funds tracked by Wall St. Rank held CareDx as of Q1 2019.

Based on Perceptive Advisors's 13F filing for Q1 2019, filed 15 May 2019.